United States Zika Cases In MMWR Week 43 Increase 41

[niman]

Zika ††,§§§§
Zika virus congenital infection	NA	NA	NA	NN	NN	NN	NN	NN
Zika virus disease, non-congenital infection	2	4,056	-	NN	NN	NN	NN	NN	VA (1 ), UT (1 )

https://wonder.cdc.gov/mmwr/mmwr_2016_38.asp?mmwr_year=2016&mmwr_week=43&mmwr_table=1&request=Submit&mmwr_location=

[niman]

TABLE I. Provisional cases of selected* infrequently reported notifiable diseases (<1,000 cases reported during the preceding year), United States,  week ending October 29, 2016 (WEEK 43)†     Disease   Total cases reported for previous years   Current week Cum 2016 5-year weekly average§ 2015 2014 2013 2012 2011 States reporting cases during current week (No.43)  Anthrax - - - - - - - 1    Arboviral diseases ¶,**:                    Chikungunya virus †† - 119 2 896 NN NN NN NN    Eastern equine encephalitis virus - 2 0 6 8 8 15 4    Jamestown Canyon virus §§ - 2 0 11 11 22 2 3    La Crosse virus §§ - 23 0 55 80 85 78 130    Powassan virus - 6 0 7 8 12 7 16    St. Louis encephalitis virus - 6 0 23 10 1 3 6    Western equine encephalitis virus - - - - - - - -    Botulism, total 1 138 4 195 161 152 168 153    foodborne - 30 0 37 15 4 27 24    infant 1 90 3 138 127 136 123 97 OH (1 )  other(wound & unspecified) - 18 1 20 19 12 18 32    Brucellosis 1 94 2 126 92 99 114 79 FL (1 )  Chancroid - 10 0 11 - - 15 8    Cholera - 2 0 2 5 14 17 40    Cyclosporiasis ** - 422 2 645 388 784 123 151    Diphtheria - - - - 1 - 1 -    Haemophilus influenzae, invasive disease (age <5 yrs) ¶¶:                    serotype b 1 18 1 29 40 31 30 14 TX (1 )  nontypeable serotype 1 115 3 175 128 141 115 93 RI (1 )  other serotype 1 103 2 135 266 233 263 230 MS (1 )  unknown serotype 3 156 3 167 39 34 37 48 MA (1 ), AL (1 ), CO (1 )  Hansen's disease ** 1 35 1 89 88 81 82 82 FL (1 )  Hantavirus Infections **:                    Hantavirus infection (non-HPS) †† - 3 0 1 NN NN NN NN    Hantavirus pulmonary syndrome (HPS) - 11 0 17 32 21 30 23    Hemolytic uremic syndrome, post-diarrheal ** 2 190 7 274 250 329 274 290 OH (1 ), MD (1 )  Hepatitis B, virus infection perinatal 1 19 1 37 47 48 40 NP PA (1 )  Influenza-associated pediatric mortality **, *** 2 81 0 130 141 160 52 118 SC (1 ), CA (1 )  Leptospirosis ** 1 39 1 40 38 NN NN NN FL (1 )  Listeriosis 8 530 17 768 769 735 727 870 VT (1 ), RI (1 ), NY (2 ), NYC (1 ), AZ (1 ), WA (2 )  Measles ††† - 59 1 188 667 187 55 220    Meningococcal disease, invasive §§§:                    serogroup ACWY - 75 3 120 123 142 161 257    serogroup B 1 55 2 111 89 99 110 159 TN (1 )  other serogroup - 13 0 21 25 17 20 20    unknown serogroup 1 144 3 120 196 298 260 323 NYC (1 )  Novel influenza A virus infections ¶¶¶ - 21 0 6 3 21 313 14    Plague - - 0 13 10 4 4 3    Poliomyelitis, paralytic - - - - - 1 - -    Polio virus infection, nonparalytic ** - - - - - - - -    Psittacosis ** - 5 0 4 8 6 2 2    Q fever total **: 2 107 2 156 168 170 135 134    acute 1 89 2 122 132 137 113 110 TX (1 )  chronic 1 18 1 34 36 33 22 24 NE (1 )  Rabies, human - - 0 1 1 2 1 6    SARS CoV - - - - - - - -    Smallpox - - - - - - - -    Streptococcal toxic shock syndrome ** - 190 3 335 259 224 194 168    Syphilis, congenital **** - 350 7 492 458 348 322 360    Toxic shock syndrome (staphylococcal) ** - 23 1 64 59 71 65 78    Trichinellosis ** - 13 0 11 14 22 18 15    Tularemia - 171 3 314 180 203 149 166    Typhoid fever 2 253 5 367 349 338 354 390 NYC (1 ), TX (1 )  Vancomycin-intermediate Staphylococcus aureus ** 3 84 4 183 212 248 134 82 MO (1 ), GA (1 ), OK (1 )  Vancomycin-resistant Staphylococcus aureus ** - - - 1 - - 2 -    Viral hemorrhagic Fevers ††††:                    Crimean-Congo hemorrhagic fever - - - - NP NP NP NP    Ebola hemorrhagic fever - - - - 4 NP NP NP    Guanarito hemorrhagic fever - - - - NP NP NP NP    Junin hemorrhagic fever - - - - NP NP NP NP    Lassa fever - - - - 1 NP NP NP    Lujo virus - - - - NP NP NP NP    Machupo hemorrhagic fever - - - - NP NP NP NP    Marburg fever - - - - NP NP NP NP    Sabia-associated hemorrhagic fever - - - - NP NP NP NP    Yellow fever - - - - - - - -    Zika ††,§§§§                    Zika virus congenital infection NA NA NA NN NN NN NN NN    Zika virus disease, non-congenital infection 2 4,056 - NN NN NN NN NN VA (1 ), UT (1 ) [ Export This Table ]  [ Next Part ]  [ NNDSS Interactive Tables ]  [ Mortality Interactive Tables ]

-: No reported cases    N: Not reportable.    NA: Not Available    NN: Not Nationally Notifiable.    NP: Nationally notifiable but not published.    Cum: Cumulative year-to-date counts.  * Case counts for reporting year 2016 are provisional and subject to change. Data for years 2011 through 2014 are finalized. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.  † This table does not include cases from the U.S. territories. Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.  § Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. Additional information is available at http://wwwn.cdc.gov/nndss/document/5yearweeklyaverage.pdf. ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly reports from the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II. ** Not reportable in all reporting jurisdictions. Data from states where the condition is not reportable are excluded from this table, except for the arboviral diseases and influenza-associated pediatric mortality. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/downloads.html.  †† Office of Management and Budget approval of the NNDSS Revision #0920-0728 on January 21, 2016, authorized CDC to receive data for these conditions. CDC is in the process of soliciting data for these conditions (except Zika virus, congenital infection). CDC and the U.S. states are still modifying the technical infrastructure needed to collect and transmit data for Zika virus congenital infections.  §§ Jamestown Canyon virus and Lacrosse virus have replaced California serogroup diseases.  ¶¶ Data for Haemophilus influenzae (all ages, all serotypes) are available in Table II. *** Updated weekly from the Influenza Division, National Center for Immunization and Respiratory Diseases. Since October 2, 2016, no influenza-associated pediatric deaths occurring during the 2016-17 season have been reported. Since October 4, 2015, 87 influenza-associated pediatric deaths occurring during the 2015-16 influenza season have been reported. ††† No measles cases were reported for the current week. §§§ Data for meningococcal disease (all serogroups) are available in Table II. ¶¶¶ All cases of novel influenza A virus infection reported to CDC since 2011 have been variant viruses. Influenza viruses that circulate in swine are called swine influenza viruses when isolated from swine, but are called variant viruses when isolated from humans. Variant influenza viruses are different from the influenza A (H1N1)pdm09 virus. Total case counts are provided by the Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD).  **** Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. †††† Prior to 2015, CDC's National Notifiable Diseases Surveillance System (NNDSS) did not receive electronic data about incident cases of specific viral hemorrhagic fevers; instead data were collected in aggregate as "viral hemorrhagic fevers". Beginning in 2015, NNDSS has been updated to receive data for each of the viral hemorrhagic fevers listed below. In addition to the four cases of Ebola diagnosed in the United States to date in 2014, six residents of the United States have been medically evacuated to the United States for care after developing Ebola in West Africa. Ten of the 11 Viral Hemorrhagic Fever cases reported for 2014 are confirmed as Ebola and one as Lassa fever. §§§§ All cases reported have occurred in travelers returning from affected areas, with their sexual contacts, or infants infected in utero. National Notifiable Diseases Surveillance System (NNDSS) MMWR web application provided by CDC WONDER,  http://wonder.cdc.gov